Clinical Trial Update: Open-Label Study of OTO-201 for Middle Ear Effusion Evaluating Trans-Tympanostomy Tube Administration [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial assessing OTO-201 administered via trans-tympanostomy tube for bilateral middle ear effusion has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Middle Ear Effusion

Drugs mentioned

• OTO-201

Snippet

Sponsor: Otonomy, Inc. | Conditions: Bilateral Middle Ear Effusion | Phase 3 | Status: COMPLETED | Results posted: 2020-09-23